Disclosures: Brandon Lehrich: Nothing to Disclose, Junyan Tao: Nothing to Disclose, Silvia Liu: Nothing to Disclose, Theo Hirsch: Nothing to Disclose, Tyler Yasaka: Nothing to Disclose, Catherine Cao: Nothing to Disclose, Evan Delgado: Nothing to Disclose, Yuqing Liu: Nothing to Disclose, Xiangnan Guan: Nothing to Disclose, Shan Lu: Nothing to Disclose, Long Pan: Nothing to Disclose, Sucha Singh: Nothing to Disclose, Minakshi Poddar: Nothing to Disclose, Aatur Singhi: Nothing to Disclose, Jessica Zucman-Rossi: Nothing to Disclose, Yulei Wang: Nothing to Disclose, Satdarshan (Paul) Monga: Alnylam: Grant/Research Support, Alnylam: Consultant, Surrozen: Independent Contractor, Fog Pharmaceuticals: Grant/Research Support, Mermaid Bio: Advisor, Vicero: Advisor, AntlerA: Advisor, Genentech: Speaking and Teaching, Surrozen: Consultant 2563 FULL LIVER CELL ATLAS OF FHF MOUSE MODEL REVEALS HSPCS AS REGULATORY HUB PROMOTING HEPATIC MICRO-ENVIRONMENT REBUILDING DURING MSC TREATMENT Jun Li 1 Heng Yao 1 Hui Yang 1 Suwan Sun 1 Xi Liang 2 Jing Jiang 1 Jiaojiao Xin 1 Dongyan Shi 1 Xin Chen 1 , 1 Zhejiang University, 2 Taizhou Central Hospital Background: Transplantation of human bone marrow mesenchymal stem cells (hBMSCs) can rescue mice with fulminant hepatic failure (FHF)
Typically, 812 sessions, taken once a week, followed by maintenance doses, show noticeable improvement
Safety Comparison Table# Research Evidence Comparison# Amycretin Research# Amycretin has early but impressive data: Phase 1 (SC): Published in The Lancet (2025)
EAAT can transport not only excitatory amino acids, for example, glutamate and aspartate, but also cysteine, in particular, EAAT3, also known as EAAC1 that can transport cysteine at a rate comparable to that of glutamate [19]
This is one of the causes of the sensory symptoms and impairment in motor function that many autistic individuals experience
